First Time Loading...

Integral Diagnostics Ltd
ASX:IDX

Watchlist Manager
Integral Diagnostics Ltd Logo
Integral Diagnostics Ltd
ASX:IDX
Watchlist
Price: 2.25 AUD 1.35% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. [ Read More ]

The intrinsic value of one IDX stock under the Base Case scenario is 4.49 AUD. Compared to the current market price of 2.25 AUD, Integral Diagnostics Ltd is Undervalued by 50%.

Key Points:
IDX Intrinsic Value
Base Case
4.49 AUD
Undervaluation 50%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Integral Diagnostics Ltd

Backtest IDX Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling IDX stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of Integral Diagnostics Ltd's business.

What risks and challenges
does Integral Diagnostics Ltd face in the near future?

Summarize the latest earnings report
of Integral Diagnostics Ltd.

Provide P/E
for Integral Diagnostics Ltd and its competitors.

Financials

Balance Sheet Decomposition
Integral Diagnostics Ltd

Current Assets 65.7m
Cash & Short-Term Investments 18m
Receivables 35.6m
Other Current Assets 12.1m
Non-Current Assets 680.1m
Long-Term Investments 5k
PP&E 276m
Intangibles 404.1m
Current Liabilities 86.1m
Accounts Payable 28.3m
Other Current Liabilities 57.8m
Non-Current Liabilities 359.4m
Long-Term Debt 343.6m
Other Non-Current Liabilities 15.7m
Efficiency

Earnings Waterfall
Integral Diagnostics Ltd

Revenue
456.3m AUD
Cost of Revenue
-21.8m AUD
Gross Profit
434.6m AUD
Operating Expenses
-392.2m AUD
Operating Income
42.4m AUD
Other Expenses
-100.2m AUD
Net Income
-57.9m AUD

Free Cash Flow Analysis
Integral Diagnostics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

IDX Profitability Score
Profitability Due Diligence

Integral Diagnostics Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive Revenue Growth Forecast
50/100
Profitability
Score

Integral Diagnostics Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

IDX Solvency Score
Solvency Due Diligence

Integral Diagnostics Ltd's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Average D/E
Short-Term Solvency
Low Altman Z-Score
27/100
Solvency
Score

Integral Diagnostics Ltd's solvency score is 27/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

IDX Price Targets Summary
Integral Diagnostics Ltd

Wall Street analysts forecast IDX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDX is 2.46 AUD with a low forecast of 1.87 AUD and a high forecast of 3.24 AUD.

Lowest
Price Target
1.87 AUD
17% Downside
Average
Price Target
2.46 AUD
9% Upside
Highest
Price Target
3.24 AUD
44% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

IDX Price
Integral Diagnostics Ltd

1M 1M
+2%
6M 6M
-22%
1Y 1Y
-22%
3Y 3Y
-51%
5Y 5Y
+2%
10Y 10Y
+57%
Annual Price Range
2.25
52w Low
1.66
52w High
3.49
Price Metrics
Average Annual Return 13.16%
Standard Deviation of Annual Returns 39.22%
Max Drawdown -68%
Shares Statistics
Market Capitalization 525.2m AUD
Shares Outstanding 233 249 475
Percentage of Shares Shorted
N/A

IDX Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Integral Diagnostics Ltd Logo
Integral Diagnostics Ltd

Country

Australia

Industry

Health Care

Market Cap

525.2m AUD

Dividend Yield

2.22%

Description

Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services to patients and their referrers across Australia and New Zealand. The firm offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. IDX also operates in New Zealand through the Ascot Radiology, SRG Radiology and Trinity MRI brands. The firm has approximately 72 radiology clinics, including 26 comprehensive sites. IDX offers its services through its subsidiaries.

Contact

VICTORIA
Melbourne
Suite 9.02, Level 9, 45 William Street
+61353390704.0
https://www.integraldiagnostics.com.au/

IPO

2015-10-21

Employees

-

Officers

CEO, MD & Director
Dr. Ian Kadish M.B.A., MBBCh
Executive Director
Dr. Jacqueline Milne MBBS
Chief Financial Officer
Mr. Scott Paterson
Chief Information Officer
Mr. Julian Gully
General Counsel & Company Secretary
Ms. Nikki Dalla Valle L.L.B.
Chief Medical Officer
Dr. Lisa Sorger MBBS

See Also

Discover More
What is the Intrinsic Value of one IDX stock?

The intrinsic value of one IDX stock under the Base Case scenario is 4.49 AUD.

Is IDX stock undervalued or overvalued?

Compared to the current market price of 2.25 AUD, Integral Diagnostics Ltd is Undervalued by 50%.